SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-15-000254
Filing Date
2015-07-20
Accepted
2015-07-17 21:43:33
Documents
2
Period of Report
2015-07-17

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER FOR JULY 17, 2015 nymoxpharma6k.htm 6-K 7024
2 DR. AVERBACK EMPLOYMENT AGREEMENT exhibit99-1.htm EX-99.1 19833
  Complete submission text file 0001176256-15-000254.txt   27901
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 15994852
SIC: 2835 In Vitro & In Vivo Diagnostic Substances